Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 685-696 of 5,650
Drug study icon
RecruitingNCT06562608

Anticholinergic Deprescription in Schizophrenia

This study is comparing Anticholinergic Deprescription with Healthy Controls for people with Schizophrenia or schizoaffective disorder. Participants receive Anticholinergic Deprescription or Healthy Controls and complete study visits and assessments.

In Pittsburgh
SchizophreniaDrugA study involving a medication or substance.From 40 Years to 70 Years
Countries
United States
Sponsor
Deepak K. Sarpal, M.D.
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05632757

Anticipated Patient and Caregiver Burden

This summary needs review. Please check the official study record and contact the research team for details.

In Marseille
DepressionBehavioralOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Depression
Behavioral study icon
RecruitingNCT06496646

Antidepressant Adherence for Depressed Adults in Primary Care

This study is looking at measure both medication adherence and depression outcomes. Participants receive a study treatment and complete follow-up visits and assessments.

In Philadelphia
DepressionBehavioralFrom 21 Years to 64 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Drug study icon
RecruitingISRCTN42305247

Antidepressant Controlled study for Negative Symptoms in schizophrenia

This study is testing a medication approach for people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

Multiple locations, including Bristol
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Imperial College London (UK)
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN12682719

Antidepressant for the prevention of depression following first-episode psychosis

This study is looking at whether a digital support tool can help people with First Episode Psychosis, Mental and Behavioural Disorders, or Unspecified nonorganic psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Depression, SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Depression, Schizophrenia
Drug study icon
RecruitingNCT06927076

Antidepressant Response of DMT Masked With Propofol

This study is looking at care and outcomes for people with depression or Psychedelic Experiences. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Basel
DepressionDrugOver 21 Years
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Condition
Depression
Drug study icon
RecruitingISRCTN25383361

Antidepressants during pregnancy: risk-benefit study for mother and child

This observational study is following people with Depression and pregnancy, Mental and Behavioural Disorders, or Depressive episode to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Netherlands
DepressionOther
Countries
Netherlands
Sponsor
University Medical Centre Utrecht (UMCU) (Netherlands)
Condition
Depression
Drug study icon
RecruitingISRCTN15969819

Antidepressants to prevent relapse in depression

This study is looking at whether a digital support tool can help people with Depression or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
DepressionOtherFrom 18 Years to 74 Years
Countries
United Kingdom
Sponsor
PRIMENT CTU, University College London
Condition
Depression
Drug study icon
RecruitingISRCTN45338259

Antiglucocorticoid augmentation of antiDepressants in Depression: the ADD study

This study is testing a medication approach for people with Major depression, Mental and Behavioural Disorders, or Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
DepressionOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Northumberland, Tyne and Wear NHS Foundation Trust (UK)
Condition
Depression
Drug study icon
RecruitingISRCTN13280178

Antipsychotic medication and weight gain: effects of neuromodulation and cognitive training

This study is testing a medication approach for people with Weight gain in taking antipsychotic medication for schizophrenia or schizoaffective disorder or Signs and Symptoms. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.